Clinical Trials for Hope Biosciences

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hope Biosciences

Clinical Trials (6)

NCT06623240
HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
PHASE2Recruiting
66 participants
Started: Oct 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06654193
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
PHASE1/PHASE2Not yet recruiting
70 participants
Started: Oct 31, 2025 · Completed: Jan 1, 2028
1 condition4 sponsors3 locations
NCT07077746
HB-adMSCs for the Treatment of Crohn's Disease
PHASE2Recruiting
46 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06800404
"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
PHASE2Enrolling by invitation
10 participants
Started: May 2, 2025 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05951777
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
PHASE2Recruiting
51 participants
Started: Apr 16, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT04995081
Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)
PHASE2Active, not recruiting
60 participants
Started: Jul 16, 2021 · Completed: Jan 15, 2026
1 condition1 sponsor1 location